BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Liu D, Wang Z, Cai C, Jiang H, Yu G. Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. FASEB J 2021;35:e21458. [PMID: 33948987 DOI: 10.1096/fj.202000763RRR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Park HB, Kim SJ, Yadav D, An EK, Zhang W, Eom HY, Kwak M, Oda T, Lee PC, Jin JO. Pyropia yezoensis-derived porphyran attenuates acute and chronic colitis by suppressing dendritic cells. Int J Biol Macromol 2023;231:123148. [PMID: 36639074 DOI: 10.1016/j.ijbiomac.2023.123148] [Reference Citation Analysis]
2 Ma K, Sheng W, Gao R, Feng J, Huang W, Cui L, Liu J, Li Y. Ethanolic extract of root from Arctium lappa L ameliorates obesity and hepatic steatosis in rats by regulating the AMPK/ACC/CPT-1 pathway. J Food Biochem 2022;46:e14455. [PMID: 36183168 DOI: 10.1111/jfbc.14455] [Reference Citation Analysis]
3 Yin G, Liang H, Sun W, Zhang S, Feng Y, Liang P, Chen S, Liu X, Pan W, Zhang F. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Front Pharmacol 2022;13:1016745. [PMID: 36506575 DOI: 10.3389/fphar.2022.1016745] [Reference Citation Analysis]
4 Geng L, Zhang Q, Suo Q, Wang J, Wang Y, Wang C, Wu N. Inhibitory activities of a sulfated oligo-porphyran from Pyropia yezoensis against SARS-CoV-2. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.120173] [Reference Citation Analysis]
5 Wang X, Dong J, Liang W, Fang Y, Liang M, Xu L, Sun W, Li X. Porphyran From Porphyra haitanensis Alleviates Obesity by Reducing Lipid Accumulation and Modulating gut Microbiota Homeostasis. Front Pharmacol 2022;13:942143. [DOI: 10.3389/fphar.2022.942143] [Reference Citation Analysis]
6 Wang X, Wang Z, Liu D, Jiang H, Cai C, Li G, Yu G. Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease. Front Pharmacol 2022;13:839640. [PMID: 35281938 DOI: 10.3389/fphar.2022.839640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]